Analiza petogodišnjih troškova liječenja bolesnika s plućnom hipertenzijom na Klinici za plućne bolesti Jordanovac Kliničkog bolničkog centra Zagreb

professional thesis

• Author: Magdalena Bejuk
• Mentor: Miroslav Samaržija (mentor)
• Granter: University of Zagreb; School of Medicine; Zagreb
• Defense date and country: 2016-03-31, Croatia
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Public Health and Health Care; Public Health

Abstract

Plućna hipertenzija nastaje kao posljedica različitih kliničkih stanja, te se ubraja u rijetke bolesti. Izlječenje plućne hipertenzije nije moguće, ali ciljanom terapijom moguće je poboljšanje u smislu očekivanog trajanja života i poboljšanje kvalitete života. Pristup liječenju ovisi o etiološkoj dijagnozi ali i o mogućnostima primjene skupih lijekova koji se danas nude na tržištu. Ciljevi ovoga rada bili su analizirati ukupnu potrošnju liječenja specifičnim vazodilatatorima bolesnika oboljelih od plućne hipertenzije na Klinici za plućne bolesti Jordanovac Kliničkog bolničkog centra Zagreb tijekom razdoblja od 2009.godine do 2013. godine. Specifični vazodilatatori koji su promatrani u ovome radu su lijekovi Sildenafil (Revatio), Bosentan (Tracleer), Iloprost (Ventavis) i Treprostinil (Remodulin). Također smo u radu proveli analizu sociodemografskih, vitalnih i kliničkih karakteristika bolesnika, te povezanost tih karakteristika sa ukupnom potrošnjom na specifične vazodilatatore. Provedena je retrospektivna kohortna studija. Kao izvor podataka koristili smo Registar bolesnika sa plućnom hipertenzijom Klinike za plućne bolesti Jordanovac Kliničkog bolničkog centra Zagreb.

Abstract (english)

Pulmonary hypertension occurs as a result of various clinical conditions and it is one of so called „Orphan Diseases“. With targeted therapy it is possible to improve the life expectancy and the quality of life, however it isn´t possible to cure the disease. Treatment options depend on the etiology of the diagnosis as well as on the possibilities of expensive drugs that are now available on the market. The aims of this study were analyzing the overall consumption of the specific vasodilatators which were given to patients with pulmonary hypertension at the Clinic for Lung Diseases Jordanovac at the Clinical Hospital Centre Zagreb during period from 2009 till 2013. The specific vasodilatators that were observed in this study are drugs: Sildenafil (Revatio), Bosentan (Tracleer), Iloprost (Ventavis) and Treprostinil (Remodulin). In this study the socio-demographic, vital and clinical characteristics of the patients were analyzed as well as their relationship with the total consumption of specific vasodilatators. We conducted a retrospective cohort study. The Registry of patients with pulmonary hypertension of the Clinic for Lung Diseases Jordanovac of the Clinical Hospital Centre Zagreb was used as a data source.

• Keywords: plućna hipertenzija; troškovi liječenja; vazodilatatori; Registar
• Keywords (english): pulmonary hypertension; costs of the Treatment; vasodilatators; registry
• Language: croatian
• URN:NBN: urn:nbn:hr:105:255210
• Study programme: Title: Leadership and management of health services; Study programme type: university; Study level: postgraduate specialist; Academic / professional title: sveučilišni/a magistar/magistra menadžmenta u zdravstvu (sveučilišni/a magistar/magistra menadžmenta u zdravstvu)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Open access
• Created on: 2020-08-10 09:50:28